All terms in NCIT
| Label | Id | Description |
|---|---|---|
| PPP2R5C Gene | NCIT_C20404 | [This gene plays a role in the negative control of cell growth and division.] |
| Benzarone | NCIT_C74411 | |
| Thrombolytic Agent | NCIT_C29750 | [Any agent capable of dissolving an existing blood clot in order to reperfuse the blocked blood vessel.] |
| Thirty One | NCIT_C126863 | [A natural number greater than thirty and less than thirty-two and the quantity that it denotes.] |
| Niemann-Pick Disease, Type C1 | NCIT_C126864 | [Type C Niemann-Pick disease associated with a mutation in the gene NPC1, encoding Niemann-Pick C1 protein.] |
| Niemann-Pick Disease, Type C | NCIT_C85214 | [An autosomal recessive inherited lysosomal storage disease caused by mutations in the NPC1 and NPC2 genes. It is characterized by progressive neurologic deterioration manifested with ataxia, dementia, seizures, and dystonia. Other signs and symptoms include hepatosplenomegaly, jaundice, and respiratory failure.] |
| Niemann-Pick Disease, Type C2 | NCIT_C126865 | [Type C Niemann-Pick disease associated with a mutation in the gene NPC2, encoding Niemann-Pick C2 protein.] |
| BTG2 wt Allele | NCIT_C49440 | [Human BTG2 wild-type allele is located in the vicinity of 1q32 and is approximately 4 kb in length. This allele, which encodes BTG2 Protein, plays a role in the regulation of the G1/S transition of the cell cycle and variant alleles may play a role B-cell chronic lymphocytic leukemia.] |
| Niemann-Pick Disease, Type B | NCIT_C126866 | [An autosomal recessive lysosomal storage disease caused by mutations in the SMPD1 gene, encoding sphingomyelin phosphodiesterase. The condition is characterized by hepatosplenomegaly and interstitial lung disease, but with little neurological involvement. It is part of a continuum of disease resulting from decrease activity of sphingomyelin phosphodiesterase, with Type B being the milder form.] |
| Niemann-Pick Disease | NCIT_C61269 | [An autosomal recessive inherited lysosomal storage disease characterized by deficiency of sphingomyelinase. It results in the accumulation of sphingomyelin in the liver, spleen, brain, lungs, and bone marrow. Signs and symptoms include hepatosplenomegaly, pancytopenia, ataxia, dystonia, and dementia.] |
| SMPD1 Gene | NCIT_C105019 | [This gene plays a role in ceramide metabolism.] |
| Efloxate | NCIT_C74416 | |
| Emopamil | NCIT_C74417 | |
| GAIA Preeclampsia Level of Diagnostic Certainty Terminology | NCIT_C126860 | [A subset of terminology related to preeclampsia, developed by the Global Alignment of Immunization safety Assessment in pregnancy consortium to aid in monitoring and improving fetal and maternal outcomes.] |
| Acoxatrine | NCIT_C74418 | |
| GAIA Pathways to Preterm Birth Level of Diagnostic Certainty Terminology | NCIT_C126861 | [A subset of terminology related to pathways to preterm birth, developed by the Global Alignment of Immunization safety Assessment in pregnancy consortium to aid in monitoring and improving fetal and maternal outcomes.] |
| Brovincamine | NCIT_C74419 | |
| Unsatisfactory | NCIT_C126862 | [Failing to meet the quantitative or qualitative measures for the needs of a situation.] |
| Amount Recovered Infinity Predicted Normalized by Body Mass Index | NCIT_C112226 | [The cumulative amount recovered extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.] |
| Amount Recovered Infinity Predicted Normalized by Surface Area | NCIT_C112227 | [The cumulative amount recovered extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.] |